Journal Home > Volume 6 , Issue 1
Journal of Neurorestoratology 2018, 6(1): 171-178 https://doi.org/10.26599/JNR.2018.9040013
Review Article | Open Access | Issue | Published: 30 December 2018

Review of clinical neurorestorative strategies for spinal cord injury: Exploring history and latest progresses

Show Author's Information Hongyun Huang1,2,  Hari Shanker Sharma3,  Lin Chen4,  Ali Otom5,  Ziad M. Al Zoubi6,  Hooshang Saberi7,  Dafin F. Muresanu8,  Xijing He9
Institute of Neurorestoratology, Third Medical Center of PLA General Hospital, Beijing, China
Hongtianji Neuroscience Academy, Lingxiu building, Beijing, China
Intensive Experimental CNS Injury and Repair, University Hospital, UppsalaUniversity, Uppsala, Sweden
Department of Neurorestoratology, Tsinghua University Yuquan Hospital, Beijing, China
Royal Specialty Center for Spine and Musculoskeletal Disorders Amman, Jordan
Jordan Ortho and Spinal Centre, Al-Saif Medical Center, Amman, Jordan
Department of Neurosurgery, Brain and Spinal cord Injury Research center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Department of Neurosciences “Iuliu Hatieganu,” University of Medicine and Pharmacy, Cluj-Napoca, Romania
Department of Orthopaedics, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Keywords:
cell therapy, spinal cord injury, neurorestorative strategies, neuromodulation, nerve bridges
Cite this article:
Huang H, Sharma HS, Chen L, et al. Review of clinical neurorestorative strategies for spinal cord injury: Exploring history and latest progresses. Journal of Neurorestoratology, 2018, 6(1): 171-178. https://doi.org/10.26599/JNR.2018.9040013
Download citation
EndNote(RIS)
BibTeX

772

Views

50

Downloads

Citations

21

Crossref

23

WoS

0

Scopus

N/A

CSCD

Abstract Full text About this article

Clinical neurorestorative therapies recently made great progress for patients with spinal cord injury (SCI). This paper systemically reviews historical perspectives, recent advancements and achievements in SCI through key neurorestorative strategies. In this study, a search was performed in the PubMed, Scopus, and Scholar Google search engines using the keywords “neurorestorative strategies”, “spinal cord injury”, “cell therapy”, “neuromodulation”, and “nerve bridges”. Clinical studies published in the English language were included. It is paramount for academic community involved in this field to take the initiative of a multicenter randomized, double-blind, and placebo-control clinical study with high level of evidence-based treatments for most SCI neurorestorative strategies in patient management. It is of utmost need to establish standard therapeutic methods for patients with SCI as early as possible.


menu
Abstract
Full text
Outline
About this article

Review of clinical neurorestorative strategies for spinal cord injury: Exploring history and latest progresses

Show Author's information Hongyun Huang1,2, Hari Shanker Sharma3, Lin Chen4, Ali Otom5, Ziad M. Al Zoubi6, Hooshang Saberi7, Dafin F. Muresanu8, Xijing He9
Institute of Neurorestoratology, Third Medical Center of PLA General Hospital, Beijing, China
Hongtianji Neuroscience Academy, Lingxiu building, Beijing, China
Intensive Experimental CNS Injury and Repair, University Hospital, UppsalaUniversity, Uppsala, Sweden
Department of Neurorestoratology, Tsinghua University Yuquan Hospital, Beijing, China
Royal Specialty Center for Spine and Musculoskeletal Disorders Amman, Jordan
Jordan Ortho and Spinal Centre, Al-Saif Medical Center, Amman, Jordan
Department of Neurosurgery, Brain and Spinal cord Injury Research center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Department of Neurosciences “Iuliu Hatieganu,” University of Medicine and Pharmacy, Cluj-Napoca, Romania
Department of Orthopaedics, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Abstract

Clinical neurorestorative therapies recently made great progress for patients with spinal cord injury (SCI). This paper systemically reviews historical perspectives, recent advancements and achievements in SCI through key neurorestorative strategies. In this study, a search was performed in the PubMed, Scopus, and Scholar Google search engines using the keywords “neurorestorative strategies”, “spinal cord injury”, “cell therapy”, “neuromodulation”, and “nerve bridges”. Clinical studies published in the English language were included. It is paramount for academic community involved in this field to take the initiative of a multicenter randomized, double-blind, and placebo-control clinical study with high level of evidence-based treatments for most SCI neurorestorative strategies in patient management. It is of utmost need to establish standard therapeutic methods for patients with SCI as early as possible.

Keywords: cell therapy, spinal cord injury, neurorestorative strategies, neuromodulation, nerve bridges

References(76)

[1]
Huang H, Chen L. Commentary: Neurorestoratology: A concept and emerging discipline in the treatment of neurological disorders. CNS Neurol Disord Drug Targets. 2016, 15(5): 522-525.
DOI Google Scholar
[2]
Huang H, Sun T, Chen L, et al. Consensus of clinical neurorestorative progresses in patients with complete chronic spinal cord injury. Cell Transplant. 2014, 23: S1-13.
DOI Google Scholar
[3]
Huang H, Mao G, Feng S, et al. 2016 yearbook of neurorestoratology. J. Neurorestoratology 2017, 5: 111-115.
DOI Google Scholar
[4]
Huang H, Skaper S, Mao G, et al. 2017 yearbook of neurorestoratology. J. Neurorestoratology 2018, 6: 67-70
DOI Google Scholar
[5]
Anderberg L, Aldskogius H, Holtz A. Spinal cord injury– Scientific challenges for the unknown future. Ups. J. Med. Sci. 2007, 112: 259-288.
DOI Google Scholar
[6]
Huang, H. Neurorestoratology, a distinct discipline and a new era: A brief introduction to the first IANR section. Cell Transplant. 2010, 19: 129-131.
DOI Google Scholar
[7]
Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study. N Engl J Med 1990, 322(20): 1405-1411.
DOI Google Scholar
[8]
Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazadmesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National acute spinal cord injury study. JAMA 1997, 277(20): 1597-1604.
DOI Google Scholar
[9]
Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazadmesylate administration after acute spinal cord injury: 1-year follow up. Results of the third national acute spinal cord injury randomized controlled trial. J Neurosurg 1998, 89(5): 699-706.
DOI Google Scholar
[10]
Bauchet LN, Lonjon FE, Perrin C, et al. Strategies for spinal cord repair after injury: A review of the literature and information. Annals of Physical and Rehabilitation Medicine 2009, 52: 330-351.
DOI Google Scholar
[11]
Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev 2012, 1: CD001046.
DOI Google Scholar
[12]
Hurlbert RJ, Hadley MN, Walters BC, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2013, 72(Suppl 2): 93-105.
DOI Google Scholar
[13]
Walters BC, Hadley MN, Hurlbert RJ, et al; American Association of Neurological Surgeons; Congress of Neurological Surgeons. Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery. 2013, 60(Suppl 1): 82-91.
DOI Google Scholar
[14]
Evaniew N, Noonan VK, Fallah N, et al. Methylprednisolone for the treatment of patients with acute spinal cord injuries: A propensity score-matched cohort study from a canadian multi-center spinal cord injury registry. J Neurotrauma 2015, 32(21): 1674-1683.
DOI Google Scholar
[15]
Hurlbert RJ, Hadley MN, Walters BC, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2015, 76(Suppl 1): S71-83.
DOI Google Scholar
[16]
Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury—A randomized, placebo- controlled trial with GM-1 ganglioside. N Engl J Med. 1991, 324(26): 1829-1838.
DOI Google Scholar
[17]
Geisler F H, Coleman W P, Grieco G, et al. The Sygen multicenter acute spinal cord injury study. Spine 2001, 26(24 Suppl): S87-98.
DOI Google Scholar
[18]
Chinnock P, Roberts I. Gangliosides for acute spinal cord injury. Cochrane Database Syst Rev 2005, 2: CD004444.
DOI Google Scholar
[19]
Resnick DK. Updated guidelines for the management of acute cervical spine and spinal cord injury. Neurosurgery 2013, 72(Suppl 2): 1.
DOI Google Scholar
[20]
Filho BTEP, De AFF, Paz HLD, et al. The effect of monosialoganglyoside (GM-1) administration in spinal cord injury. Acta Ortopedica Brasileira 2016, 24(3): 123-126.
DOI Google Scholar
[21]
Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazadmesylate administration after acute spinal cord injury: 1-year follow up. Results of the third national acute spinal cord injury randomized controlled trial. J Neurosurg. 1998, 89(5): 699-706.
DOI Google Scholar
[22]
Alibai EA, Baghban F, Farrokhi MR, et al. Effects of human erythropoietin on functional outcome of patients with traumatic cervical cord injury; a pilot randomized clinical trial. Bull Emerg Trauma. 2015, 3(3): 79-85.
Google Scholar
[23]
Casha S, Zygun D, McGowan MD, et al. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain. 2012, 135(Pt 4): 1224-1236.
DOI Google Scholar
[24]
Wu JC, Huang WC, Tsai YA, et al. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: A preliminary Phase I clinical study. J Neurosurg Spine. 2008, 8(3): 208-214.
DOI Google Scholar
[25]
Derakhshanrad N, Saberi H, Yekaninejad MS, et al. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double- blind randomized controlled clinical trial. J Neurosurg Spine. 2018, 29(1): 97-107.
DOI Google Scholar
[26]
Galanda M, Nádvorník P, Fröhlich J. Surgical treatment of spasticity in spinal cord injuries (critical comments on longitudinal myelotomy). Bratisl Lek Listy. 1974, 61(5): 589-594.
Google Scholar
[27]
Yamada S, Perot PL Jr, Ducker TB, et al. Myelotomy for control of mass spasms in paraplegia. J Neurosurg. 1976, 45(6): 683-691.
DOI Google Scholar
[28]
Borovich B, Peyser E, Gruskiewicz J. Acute central and intermediate cervical cord injury. Neurochirurgia (Stuttg). 1978, 21(3): 77-84.
DOI Google Scholar
[29]
Wu G, Zhao L. Field Surgery. Shanghai Scientific and Technologic Press, 1981.
[30]
Tachibana S, Okada K, Ohwada T, et al. Posterior longitudinal myelotomy as a surgical treatment of acute cervical spinal cord injury. No Shinkei Geka. 1984, 12(2): 183-188.
Google Scholar
[31]
Koyanagi I, Iwasaki Y, Isu T, et al. Myelotomy for acute cervical cord injury. Report of four cases. Neurol Med Chir (Tokyo). 1989, 29(4): 302-306.
DOI Google Scholar
[32]
Carlsson CA, Sundin T. Reconstruction of efferent pathways to the urinary bladder in a paraplegic child. Rev Surg. 1967, 24(1): 73-76.
Google Scholar
[33]
Zhang S, Johnston L, Zhang Z, et al. Restoration of stepping- forward and ambulatory function in patients with paraplegia: rerouting of vascularized intercostal nerves to lumbar nerve roots using selected interfascicular anastomosis. Surg Technol Int. 2003, 11: 244-248.
Google Scholar
[34]
von Wild KR, Brunelli GA. Restoration of locomotion in paraplegics with aid of autologous bypass grafts for direct neurotisation of muscles by upper motor neurons—the future: Surgery of the spinal cord? Acta Neurochir Suppl. 2003, 87: 107-112.
DOI Google Scholar
[35]
Livshits A, Catz A, FolmanY, et al. Reinnervation of the neurogenic bladder in the late period of the spinal cord trauma. Spinal Cord. 2004, 42(4): 211-217.
DOI Google Scholar
[36]
Xiao CG, Du MX, Dai C, et al. An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: Preliminary results in 15 patients. J Urol. 2003, 170(4 Pt 1): 1237-1241.
DOI Google Scholar
[37]
Iumashev GS, Aganesov AG. Reconstructive surgery in complicated trauma of the thoracic and lumbar segments of the spine. Vestn Khir Im I IGrek. 1989, 143(11): 61-64.
Google Scholar
[38]
He Z, ZhangY, Song L, et al. preliminary report of fetal brain transplantation into spinal cord for traumatic paraplegia. Shanghai Medicine. 1995, 18: 650-652.
Google Scholar
[39]
Falci S, Holtz A, Akesson E, et al. Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. J Neurotrauma. 1997, 14(11): 875-884.
DOI Google Scholar
[40]
Huang H, Chen L, Wang H, et al. Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl). 2003, 116(10): 1488-1491.
Google Scholar
[41]
Rabinovich SS, Seledtsov VI, Poveschenko OV, et al. Transplantation treatment of spinal cord injury patients. Biomed Pharmacother. 2003, 57(9): 428-433.
DOI Google Scholar
[42]
Kang KS, Kim SW, Oh YH, et al. A 37-year-old spinal cord- injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy. 2005, 7(4): 368-373.
DOI Google Scholar
[43]
Chernykh ER, Stupak VV, Muradov GM, et al. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull ExpBiol Med. 2007, 143(4): 543-547.
DOI Google Scholar
[44]
Deda H, Inci MC, Kürekçi AE, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow- derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy. 2008, 10(6): 565-574.
DOI Google Scholar
[45]
Kumar AA, Kumar SR, Narayanan R, et al. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant. 2009, 7(4): 241-248.
Google Scholar
[46]
Moviglia GA, Fernandez Viña R, Brizuela JA, et al. Combined protocol of cell therapy for chronic spinal cord injury (by IV and IA). Report on the electrical and functional recovery of two patients. Cytotherapy. 2006, 8(3): 202-209.
DOI Google Scholar
[47]
Huang H, Xi H, Chen L, et al. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant 2012, 21: S23-S31
DOI Google Scholar
[48]
von Wild K, Rabischong P, Brunelli G, et al. Computer added locomotion by implanted electrical stimulation in paraplegic patients (SUAW). Acta Neurochir Suppl. 2002, 79: 99-104.
DOI Google Scholar
[49]
Minassian K, Jilge B, Rattay F, et al. Stepping-like movements in humans with complete spinal cord injury induced by epidural stimulation of the lumbar cord: electromyographic study of compound muscle action potentials. Spinal Cord. 2004, 42(7): 401-416.
DOI Google Scholar
[50]
Fregni F, Boggio PS, Lima MC, et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain. 2006, 122(1-2): 197-209.
DOI Google Scholar
[51]
Harkema S, Gerasimenko Y, Hodes J, et al. Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study. Lancet. 2011, 377(9781): 1938-1947.
DOI Google Scholar
[52]
Soler MD, Kumru H, Pelayo R, et al. Effectiveness of transcranial direct current stimulation and visual illusion on neuropathic pain in spinal cord injury. Brain. 2010, 133(9): 2565-2577.
DOI Google Scholar
[53]
Kern H, Carraro U, Adami N, et al. Home-based functional electrical stimulation rescues permanently denervated muscles in paraplegic patients with complete lower motor neuron lesion. Neurorehabil Neural Repair. 2010, 24(8): 709-721.
DOI Google Scholar
[54]
Angeli CA, Boakye M, Morton RA, et al. Recovery of over-ground walking after chronic motor complete spinal cord injury. N Engl J Med. 2018, 379(13): 1244-1250.
DOI Google Scholar
[55]
Gill ML, Grahn PJ, Calvert JS, et al. Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia. Nat Med. 2018, 24(11): 1677-1682.
DOI Google Scholar
[56]
Simeral JD, Kim SP, Black MJ, et al. Neural control of cursor trajectory and click by a human with tetraplegia 1000 days after implant of an intracortical microelectrode array. J Neural Eng. 2011, 8(2): 025027
DOI Google Scholar
[57]
Hochberg LR, Bacher D, Jarosiewicz B, et al. Reach and grasp by people with tetraplegia using a neurally controlled robotic arm. Nature. 2012, 485(7398): 372-375.
DOI Google Scholar
[58]
Onose G, Grozea C, Anghelescu A, et al. On the feasibility of using motor imagery EEG-based brain-computer interface in chronic tetraplegics for assistive robotic arm control: A clinical test and long-term post-trial follow-up. Spinal Cord. 2012, 50(8):599-608.
DOI Google Scholar
[59]
Collinger JL, Wodlinger B, Downey JE, et al. High- performance neuroprosthetic control by an individual with tetraplegia. Lancet.2012, pii: S0140-6736(12)61816-9.
Google Scholar
[60]
Mignardot JB, Le Goff CG, van den Brand R, et al. A multidirectional gravity-assist algorithm that enhances locomotor control in patients with stroke or spinal cord injury. Sci Transl Med. 2017, 9(399): eaah3621.
DOI Google Scholar
[61]
Bryukhovetskiy. Tissue Engineering in Neurorestoratology. Huang H, Raisman G, Sanberg PR, Sharma H, Chen L, eds. New York, Nova Biomedical, 2015.
[62]
Zhao Y, Tang F, Xiao Z, et al. Clinical study of neuroregen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury. Cell Transplant. 2017, 26(5): 891-900.
DOI Google Scholar
[63]
Kucher K, Johns D, Maier D, et al. First-in-man intrathecal application of neurite growth-promoting Anti-Nogo-A antibodies in acute spinal cord injury. Neurorehabil Neural Repair. 2018, 32(6–7): 578-589.
DOI Google Scholar
[64]
McDonald JW, Becker D, Sadowsky CL, et al. Late recovery following spinal cord injury.Case report and review of the literature. J Neurosurg. 2002, 97(2 Suppl): 252-265.
DOI Google Scholar
[65]
Harness ET, Yozbatiran N, Cramer SC. Effects of intense exercise in chronic spinal cord injury. Spinal Cord. 2008, 46(11): 733-737.
DOI Google Scholar
[66]
Manella KJ, Torres J, Field-Fote EC. Restoration of walking function in an individual with chronic complete (AIS A) spinal cord injury. J Rehabil Med. 2010, 42(8): 795-798.
DOI Google Scholar
[67]
Goldsmith HS, Neil-Dwyer G, Barsoum L. Omental transposition to the chronically injured human spinal cord. Paraplegia. 1986, 24(3): 173-174.
DOI Google Scholar
[68]
Cheng H, Liao KK, Liao SF, et al. Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (Phila Pa 1976). 2004, 29(14): E284-288.
DOI Google Scholar
[69]
Steeves J, Fawcett J, Tuszynski M. Report of International Clinical Trials Workshop on Spinal Cord Injury February 20–21, 2004, Vancouver, Canada. Spinal Cord. 2004, 42: 591-597
DOI Google Scholar
[70]
Negrin J Jr. Spinal cord hypothermia in the neurosurgical management of the acute and chronic post-traumatic paraplegic patient. Paraplegia. 1973, 10(4): 336-343.
DOI Google Scholar
[71]
Gao X, Gao C, Gao J, et al. Acupuncture treatment of complete traumatic paraplegia—Analysis of 261 cases. J Tradit Chin Med. 1996, 16(2): 134-137.
Google Scholar
[72]
Cheng PT, Wong MK, Chang PL. A therapeutic trial of acupuncture in neurogenic bladder of spinal cord injured patients—A preliminary report. Spinal Cord. 1998, 36(7): 476-480.
DOI Google Scholar
[73]
Moviglia GA, Varela G, Brizuela JA, et al. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord. 2009, 47(6): 499-503.
DOI Google Scholar
[74]
Seledtsova GV, Rabinovich SS, Belogorodtsev SN, et al. Delayed results of transplantation of fetal neurogenic tissue in patients with consequences of spinal cord trauma. Bull Exp Biol Med. 2010, 149(4): 530-533.
DOI Google Scholar
[75]
Geffner LF, Santacruz P, Izurieta M, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies. Cell Transplant. 2008, 17(12): 1277-1293.
DOI Google Scholar
[76]
Bohbot A. Olfactory ensheathing glia transplantation combined with LASERPONCTURE in human spinal cord injury: Results measured by electromyography monitoring. Cell Transplant. 2010, 19(2): 179-184.
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Received: 01 December 2018
Accepted: 17 December 2018
Published: 30 December 2018
Issue date: December 2018

Copyright

© The author(s) 2018

Rights and permissions

© The authors 2018. This article is published with open access at http://jnr.tsinghuajournals.com

Return